Digital Fertility Care Provider Ovom Care Raises €4.8 Million in Seed Funding – FUNDING NEWS

Ovom Care combines cutting-edge AI technologies with reproductive care to improve patient outcomes and provide women with more access to fertility at more reasonable costs. With over 100 patients treated in only a few months, Ovom Care has gained significant attention.

Ovom Care is well-positioned to dominate the fertility technology market and improve patient outcomes thanks to a strong team that includes experts in medicine, technology, and embryology.

The ground-breaking services offered by Ovom Care will be expanded throughout Europe thanks to the Seed investment. Near the end of 2024, Ovom Care will open its first directly owned clinic in Portugal, demonstrating its dedication to expanding its distinctive care model.

Read also - Milan-based Glaut Raises over €1.3 Million in Pre-Seed Funding – FUNDING NEWS

Better patient outcomes will ultimately result from the investment, which will also speed up improvements to Ovom's AI platform, broaden the company's service offerings, and support continuing research to further our understanding of reproductive health.

The business trains algorithms that serve as medical decision support tools, assisting physicians and embryologists in making individualised decisions for patients, using historical and current patient data.

This allows for more dynamic pricing and better results, including refunds in the event that a pregnancy is not attained. Patients might have a better experience during the often emotionally and financially difficult road towards parenting when the financial risk is removed.

Felicia von Reden, Co-founder and CEO said, “I believe we’re on the brink of a revolution in fertility care. I’m proud to spearhead this transformative journey together with my two co-founders Dr. Lynae Brayboy and Dr. Cristina Hickman. We are dedicated to defining a new era in reproductive care empowering every human that seeks to build a family to become a parent. Our mission is threefold: drastically improving treatment success rates, increasing accessibility, and driving patient centricity and convenience along the fertility journey.”

Terry Chou, partner at Alpha Intelligence Capital, said, “Before investing in Ovom Care, we have spent the year comparing various AI-enabled fertility solutions and assessment tools. Ovom being a digital-first AI-enabled clinic, has provided a great platform for different AI-powered fertility solutions to bring together their value, a collective intelligence revolutionising the reproductive care space”

Mascha Bonk, Investment Manager at Ananda Impact Ventures, states: “Globally, 17.5% of the adult population – roughly 1 in 6 – experience infertility. For many, in vitro fertilisation (IVF) represents a beacon of hope on their journey to becoming a parent but presents considerable financial and emotional challenges, with treatment costs ranging from EUR 15-30k and success rates hovering around 35%. With their revolutionary approach, Ovom Care is making treatments more successful, accessible, and patient-friendly. We are proud to support Ovom Care in their journey to build a future where family becomes a possibility for everyone.”

About Ovom Care

Ovom is redefining the way patients get reproductive care by fusing cutting-edge AI-based technology with contemporary in-person care. They provide an environment that enables higher success rates, better accessibility, and less interruption of patients' lives for both patients and healthcare professionals.